Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News bioAffinity Technologies Inc BIAF

bioAffinity Technologies, Inc. is a biotechnology company focused on the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatments. It develops noninvasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis developed by machine learning, a form of artificial... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:BIAF)

bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases

Business Wire October 28, 2025

bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025

Business Wire October 20, 2025

bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer

Business Wire October 16, 2025

bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements

Business Wire October 15, 2025

WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

PR Newswire October 9, 2025

bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

Business Wire October 9, 2025

WallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

PR Newswire October 8, 2025

bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

Business Wire October 8, 2025

bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025

Business Wire October 7, 2025

Opinion & Analysis (NDAQ:BIAF)

No current opinion is available.

Bullboard Posts (NDAQ:BIAF)

Buy buddy buy.

Otherwise it will be FOMO time for you fellas out there today,so good luck to all of you
coolfooldumbguy - October 8, 2025

RE:BIAF....take wild guess?

BIAF ....N.L.O.D $4.04..... Now what???
Iseneschal - September 29, 2025

BIAF....take wild guess?

N.L.O.D $4.75
Iseneschal - September 26, 2025

RE:BIAF....Dips like that....tell me it's "coin toss" time

Coin was tossed and I won....LoL.....now at $5.29....if this goes lower and breaks the final support at $5.09.....consider yourselves.....
Iseneschal - September 26, 2025

BIAF....do it Mr. Maggot

JUst do it !!!!!!!!!!!!!!!!!!!!!
Iseneschal - September 26, 2025

BIAF....Dips like that....tell me it's "coin toss" time

Place ur bets Now at $6
Iseneschal - September 26, 2025